| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $574,379 ) |
| 2025 | 2025 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 000 | 5 | NIH | 10/29/2024 | $574,379 |
| 2025 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | CE146926 | Community Project Funding/Congressionally Directed Spending - Construction | 05 | 1 | HRSA | 11/14/2024 | $0 |
| 2025 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | CE146926 | Community Project Funding/Congressionally Directed Spending - Construction | 04 | 1 | HRSA | 11/13/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,832,805 ) |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 000 | 4 | NIH | 11/20/2023 | $579,310 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 001 | 4 | NIH | 8/7/2024 | $51,495 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 000 | 1 | FDA | 12/27/2023 | $307,000 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 001 | 2 | FDA | 12/29/2023 | $50,000 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 002 | 1 | FDA | 4/24/2024 | $0 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 003 | 2 | FDA | 6/27/2024 | $450,000 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 004 | 2 | FDA | 9/14/2024 | $100,000 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 007 | 2 | FDA | 9/19/2024 | $0 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 006 | 2 | FDA | 9/16/2024 | $295,000 |
| 2024 | 2024 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 005 | 2 | FDA | 9/16/2024 | $0 |
| 2024 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 02 | 4 | HRSA | 6/20/2024 | $0 |
| 2024 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 01 | 4 | HRSA | 2/22/2024 | $0 |
| 2024 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | R01CA262460 | Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma | 000 | 3 | NIH | 9/10/2024 | $0 |
| 2024 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | CE146926 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 11/16/2023 | $0 |
| 2024 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2413 | HONOLULU | USA | U01FD007583 | Hispanic, black and pacific islandeR perspectives on COVID-19 oUtreach Strategies and patient centered outcomes (HeAR US) | 000 | 1 | FDA | 3/18/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,691,884 ) |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | R21DK133754 | TWEAK-Fn14 regulation of non-canonical NF-kB signaling in chronic renal inflammation | 000 | 1 | NIH | 8/14/2023 | $222,500 |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | R21DK133754 | TWEAK-Fn14 regulation of non-canonical NF-kB signaling in chronic renal inflammation | 001 | 1 | NIH | 9/7/2023 | $445,000 |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | U01FD007974 | Hawai‘i Health Equity Research and Outreach Network (HAWAI‘I HERON) | 000 | 1 | FDA | 5/19/2023 | $499,514 |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 000 | 3 | NIH | 11/30/2022 | $606,281 |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 001 | 3 | NIH | 3/23/2023 | $31,909 |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 00 | 4 | HRSA | 7/19/2023 | $300,000 |
| 2023 | 2023 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | R01CA262460 | Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma | 000 | 3 | NIH | 8/4/2023 | $586,680 |
| 2023 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | CE146926 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/7/2022 | $0 |
| 2023 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | CE146926 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 4/28/2023 | $0 |
| 2023 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 03 | 3 | HRSA | 3/16/2023 | $0 |
| 2023 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 01 | 3 | HRSA | 2/6/2023 | $0 |
| 2023 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2402 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 02 | 3 | HRSA | 3/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $5,150,002 ) |
| 2022 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 00 | 3 | HRSA | 7/13/2022 | $298,898 |
| 2022 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | R01CA262460 | Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma | 000 | 2 | NIH | 8/30/2022 | $238,598 |
| 2022 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | CE146926 | Community Project Funding/Congressionally Directed Spending - Construction | 00 | 1 | HRSA | 8/16/2022 | $3,000,000 |
| 2022 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 000 | 2 | NIH | 11/19/2021 | $579,304 |
| 2022 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 001 | 2 | NIH | 6/9/2022 | $64,368 |
| 2022 | 2022 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | U01FD007583 | Hispanic, black and pacific islandeR perspectives on COVID-19 oUtreach Strategies and patient centered outcomes (HeAR US) | 000 | 1 | FDA | 3/28/2022 | $968,834 |
| 2022 | 2021 | The Queen'S Medical Center | 1301 Punchbowl St | Honolulu | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 01 | 2 | HRSA | 1/5/2022 | $0 |
| 2022 | 2021 | The Queen'S Medical Center | 1301 Punchbowl St | Honolulu | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 02 | 2 | HRSA | 3/2/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,483,423 ) |
| 2021 | 2021 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | R01CA262460 | Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma | 000 | 1 | NIH | 6/24/2021 | $520,008 |
| 2021 | 2021 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | R01AT011162 | Modulation of pain mechanisms by cannabis-derived phytochemicals. | 000 | 1 | NIH | 11/24/2020 | $663,415 |
| 2021 | 2021 | THE QUEEN'S MEDICAL CENTER | 1301 PUNCHBOWL ST | HONOLULU | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 00 | 2 | HRSA | 7/1/2021 | $300,000 |
| 2021 | 2020 | The Queen'S Medical Center | 1301 Punchbowl St | Honolulu | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 03 | 1 | HRSA | 10/15/2020 | $0 |
| 2021 | 2020 | The Queen'S Medical Center | 1301 Punchbowl St | Honolulu | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 02 | 1 | HRSA | 10/6/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $300,000 ) (Continued on the next page) |
| 2020 | 2020 | The Queen'S Medical Center | 1301 Punchbowl St | Honolulu | HI | 96813-2499 | HONOLULU | USA | H2A39970 | Telehealth Network Grant Program | 01 | 1 | HRSA | 9/8/2020 | $0 |
|